FHU CARE 2 : Cancer and Autoimmune / inflammatory diseases Relationships - 2

Improve the treatment of cancer and auto-immune disease benefiting from collaboration in both fields using immunology. Immunology is the common language to all participants.
** Short summary **
The second phase of the Hospital-University Federation (FHU) CARE focuses on the intersection of cancer and autoimmune diseases. This initiative unites top specialists in autoimmune diseases, researchers in immunology and oncology, and leading oncologists and hematologists to revolutionize patient care.
We aim to advance treatments, especially cutting-edge cancer immunotherapies like CAR-T cells and bispecific antibodies, for autoimmune diseases. Our goal is to enhance treatment efficacy and tolerability, with the ultimate vision of achieving cures. Thank you for your attention.